Second Sight Medical Products (EYES) 17.44 $EYES Second

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Second Sight Medical Products (EYES) 17.44 $EYES

Second Sight Medical Products (EYES) Stock Soars Today After Increasing Implant Success
at The Street - Thu Mar 05, 1:36PM CST
Shares of Second Sight Medical Products (EYES) jumped in afternoon trading after the company announced that two newly approved centers successfully completed their first commercial implants.
EYES: 17.44 (+0.37)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:45AM CST

CRMD: 8.25 (+0.49), EYES: 17.44 (+0.37), ECR: 6.51 (-0.06), CECE: 12.65 (-0.13), DRAM: 2.47 (-0.30), NVGN: 3.15 (+0.17), AMED: 27.62 (-0.73), VSLR: 10.72 (-0.63), MOMO: 11.03 (-0.06), GEF: 36.89 (-0.89), RNDY: 4.60 (-0.08), SMTC: 27.06 (+0.76), EVOK: 6.22 (+0.19), KYTH: 53.13 (+3.13), GERN: 3.50 (-0.28), LTRE: 1.67 (-0.06), ENRJ: 2.62 (+0.11), PEIX: 11.33 (-0.42), ALG: 56.81 (-2.38), CAPN: 7.11 (-0.26)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 8:15AM CST

JOY: 39.05 (-0.89), EYES: 17.44 (+0.37), KR: 74.35 (+0.04), PCYC: 254.56 (+0.34), ONCY: 0.90 (-0.15), NAVB: 1.67 (-0.03), ERJ: 33.06 (-0.27), MVIS: 2.42 (+0.04), ARWR: 7.75 (-0.19), ASTI: 1.43 (-0.02), CLDN: 24.00 (+2.54), TGTX: 15.16 (-0.43), NVGN: 3.15 (+0.17), VSLR: 10.72 (-0.63), ACHN: 11.39 (+0.40), KYTH: 53.13 (+3.13), AVEO: 1.50 (+0.08), PEIX: 11.33 (-0.42), IFON: 2.59 (+0.07)

Second Sight's Euro Momentum
Dallas Salazar - at Seeking Alpha - Mon Mar 02, 7:02AM CST

EYES: 17.44 (+0.37)

Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 17.44 (+0.37), ABTL: 14.46 (-0.31), XIN: 3.11 (-0.08), AVEO: 1.50 (+0.08), TTI: 5.38 (-0.14), CLNE: 5.47 (-0.07)

Why Second Sight Medical Products Inc. Vaulted Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 27, 12:41PM CST
Although we don't believe in   timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Al Mann's vision-restoring...
EYES: 17.44 (+0.37), MNKD: 5.47 (-0.26)

Why Second Sight Medical Products, Inc. Soared Today
Daniel Sparks, The Motley Fool - Motley Fool - Tue Feb 24, 4:28PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of medical manufacturer and marketer of...
EYES: 17.44 (+0.37)

Second Sight Medical Products (EYES) Stock Higher Today After Success of Implants
at The Street - Tue Feb 24, 10:08AM CST
Shares of Second Sight Medical Products (EYES) are up after the company announced that its visual prosthetics have successfully been implanted in patients with retinitis pigmentosa in France.
EYES: 17.44 (+0.37)

Bioness neuromodulator cleared by FDA
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 8:43AM CST

BSX: 16.56 (-0.41), EYES: 17.44 (+0.37), MDT: 76.48 (-2.02), NURO: 1.69 (-0.06), STJ: 66.53 (-1.20), MNKD: 5.47 (-0.26)

Second Sight up premarket on implant progress
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 8:25AM CST

EYES: 17.44 (+0.37), MNKD: 5.47 (-0.26)

Update: Second Sight Gets Renewed Approval For Treatment Of 30,000 Germans
Dallas Salazar - at Seeking Alpha - Sat Feb 07, 12:13AM CST

EYES: 17.44 (+0.37)

Why Shares of Second Sight Medical Products, Inc. Jumped Today
George Budwell, The Motley Fool - Motley Fool - Tue Feb 03, 2:29PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Second Sight Medical Products saw its shares jump...
EYES: 17.44 (+0.37)

Second Sight Receives Highest Priority Reimbursement for Argus II in Germany
Business Wire - Tue Feb 03, 6:01AM CST
Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company" , a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that InEK(1), the German national system which provides health insurance to 90% of the country's population, has renewed Status 1 for the Argus(R) II Retinal Prosthesis System under the NUB(2) innovation program.
EYES: 17.44 (+0.37)

Global Retinal Surgery Devices Market 2015-2019 with Alcon, Bausch & Lomb, Iridex & Synergetics USA Dominating
M2 - Sat Jan 31, 1:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/vfpj68/global_retinal) has announced the addition of the "Global Retinal Surgery Devices Market 2015-2019" report to their offering. The Global Retinal Surgery Devices market to grow at a CAGR of 7.32% over the period 2014-2019. The human eye is the most vital sensory organ. Ophthalmic diagnostic devices are used to identify and rectify ophthalmic disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. Common eye problems can be caused by an infection or can be congenital. Continuous advances in the technology of ophthalmic devices ensure efficient diagnosis and treatment. Ophthalmic devices play a major role in treating loss of vision and improving quality of life of patients. Increased use of vitrectomy machines in the treatment of retinal detachment and vitreous hemorrhage is one key trend in this market. This is because of the availability of high-quality vitrectomy machines in the market with a cutting speed of approximately 2,500 cuts/min. According to the report, increase in aging population is one of the major drivers in the market. The growing incidence of retinal disorders, such as diabetic retinopathy, AMD, macular degeneration, retinal tear, and retinal detachments among the elderly results in increased demand for retinal surgeries to prevent loss of vision. Further, the report states that the presence of substitutes for retinal surgeries is one of the major challenges that the market faces. There are several drugs available in the market for the treatment of retinal disorders. The Global Retinal Surgery Devices market is divided into four segments: Vitrectomy Packs, Retinal Lasers, Vitrectomy Machines and Others (Retinal implants, scleral buckles, light sources, light pipes, cryosurgery devices, retinal laser probes, and surgical instruments). Key Vendors - Alcon - Bausch & Lomb - Iridex - Synergetics USA Other Prominent Vendors - ASICO - Beaver-Visitec International - Biotech Visioncare - Carl Zeiss Meditec - Ellex Medical Lasers - Erbe Elektromedizin - Escalon Medical - Geuder - Insight Instruments - Lumenis - Nano Retina - Oertli Instrumente - Peregrine Surgical - Quantel Medical - Retina Implant - Rhein Medical - Second Sight Medical Products Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product Type - Incidence and Prevalence of Retinal Disorders - Regulatory Environment - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/vf...al_retinal
EYES: 17.44 (+0.37), ESMC: 1.61 (-0.03)

IPO Preview: Spark Therapeutics
IPOdesktop - Seeking Alpha - Fri Jan 30, 8:02AM CST
Based in Philadelphia, PA, Spark Therapeutics (Pending: ONCE ) scheduled an $88 million IPO on Nasdaq with a market capitalization of $352 million at a price range midpoint of $16 for Friday, Jan. 30, 2015. Price range midpoint raised to $20, no...
EYES: 17.44 (+0.37), ONCE: 58.01 (+0.48), PFE: 33.97 (-0.50)

Presbia Puts Your Reading Glasses In Your Eyeball
IPO Candy - at Seeking Alpha - Thu Jan 29, 8:02AM CST

AMSG: 60.25 (-0.64), EYES: 17.44 (+0.37), LMNS: 11.71 (-0.26), LENS: 7.34 (-0.05)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 89

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 302

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 90

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 188

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 100

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 57

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 103

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading

Top 5 Most Recently Viewed Articles

FMC Corporation Faces Class Action Suit for Securities Fraud

Updated Category News Views 229

FMC Corporation Faces Class Action Suit for Securities Fraud The Rosen Law Firm, a prominent global firm advocating for investor rights, has initiated a class action lawsuit on behalf of purchasers of FMC Corporation (NYSE: FMC) securities. This lawsuit encompasses transactions made between specific dates in 2023 and 2025, referred to as the "Class Period." A prior...

Continue Reading
Verde Resources' BioAsphalt™ Demonstrates Carbon Sequestration Potential

Updated Category News Views 210

Verde's Innovative BioAsphalt™ Delivers Promising Validation Verde Resources Inc. (OTCQB: VRDR), a pioneering entity focused on sustainable infrastructure solutions, is proud to announce remarkable initial validation of its Biochar-Asphalt technology. This breakthrough was showcased at a renowned test track, highlighting the material's capabilities in sequestering...

Continue Reading
REGENXBIO Conference Call to Reveal Q3 Financial Insights

Updated Category News Views 71

REGENXBIO to Host a Key Conference Call REGENXBIO Inc. (NASDAQ: RGNX) has announced an important conference call aimed at discussing its financial results for the recently concluded third quarter. The call is scheduled for a weekday afternoon, at 4:30 p.m. ET. Participants can expect a thorough discussion on the financial performance that was achieved by REGENXBIO during...

Continue Reading
AppFolio Celebrates Ranking Among Fortune's Future 50 List

Updated Category News Views 256

AppFolio's Recent Achievements Highlight Company Growth AppFolio, the technology leader transforming the real estate sector, recently announced exciting news regarding its recognition by Fortune magazine. The company has been honored with a spot on Fortune's prestigious Future 50 and Best Workplaces in Technology lists. This acknowledgment underlines AppFolio's commitment...

Continue Reading
NDBN Teams Up with CareSource to Combat Diaper Shortage

Updated Category News Views 91

Introduction to the New Partnership The National Diaper Bank Network (NDBN) has formed a significant partnership with CareSource, a managed care organization renowned for its commitment to health and wellness. This collaboration aims to alleviate diaper need across the nation, providing essential support to families facing financial challenges. The Scope of Diaper Need in...

Continue Reading